151 related articles for article (PubMed ID: 33268287)
1. Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer.
Batra A; Rigo R; Hannouf MB; Cheung WY
Clin Colorectal Cancer; 2021 Jun; 20(2):e75-e81. PubMed ID: 33268287
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group.
Sato A; Kurihara M; Horikoshi N; Aiba K; Kikkawa N; Shirouzu K; Mitachi Y; Sakata Y; Wakui A
Anticancer Drugs; 1999 Sep; 10(8):741-8. PubMed ID: 10573207
[TBL] [Abstract][Full Text] [Related]
3. Raltitrexed in the treatment of elderly patients with advanced colorectal cancer: an active and low toxicity regimen.
Feliu J; Mel JR; Camps C; Escudero P; Aparicio J; Menéndez D; García Girón C; Rodriguez MR; Sánchez JJ; González Barón M;
Eur J Cancer; 2002 Jun; 38(9):1204-11. PubMed ID: 12044507
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO).
Bozkurt O; Karaca H; Ciltas A; Kaplan MA; Benekli M; Sevinc A; Demirci U; Eren T; Kodaz H; Isikdogan A; Ozkan M; Buyukberber S
Asian Pac J Cancer Prev; 2014; 15(4):1845-9. PubMed ID: 24641419
[TBL] [Abstract][Full Text] [Related]
5. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
Cocconi G; Cunningham D; Van Cutsem E; Francois E; Gustavsson B; van Hazel G; Kerr D; Possinger K; Hietschold SM
J Clin Oncol; 1998 Sep; 16(9):2943-52. PubMed ID: 9738562
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study.
Ghiringhelli F; Vincent J; Bengrine L; Borg C; Jouve JL; Loffroy R; Guiu B; Blanc J; Bertaut A
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2357-2363. PubMed ID: 31273511
[TBL] [Abstract][Full Text] [Related]
7. Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma.
Osterlund P; Orpana A; Elomaa I; Repo H; Joensuu H
Br J Cancer; 2002 Sep; 87(6):591-9. PubMed ID: 12237767
[TBL] [Abstract][Full Text] [Related]
8. Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy.
Tsavaris N; Kosmas C; Vadiaka M; Koufos C
BMC Cancer; 2002; 2():2. PubMed ID: 11860608
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of infusional biomodulated 5-fluorouracil in metastatic colorectal cancer after raltitrexed failure.
Decoster L; Neyns B; Akouaouach H; Fontaine C; Schallier D; De Grève JL
Anticancer Res; 2004; 24(3b):2037-40. PubMed ID: 15274397
[TBL] [Abstract][Full Text] [Related]
10. S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial.
Chen Y; Wu J; Cheng K; Li ZP; Luo DY; Qiu M; Gou HF; Yi C; Li Q; Wang X; Yang Y; Cao D; Shen YL; Bi F; Liu JY
Oncologist; 2019 May; 24(5):591-e165. PubMed ID: 30651398
[TBL] [Abstract][Full Text] [Related]
11. Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).
Cascinu S; Graziano F; Ferraù F; Catalano V; Massacesi C; Santini D; Silva RR; Barni S; Zaniboni A; Battelli N; Siena S; Giordani P; Mari D; Baldelli AM; Antognoli S; Maisano R; Priolo D; Pessi MA; Tonini G; Rota S; Labianca R
Ann Oncol; 2002 May; 13(5):716-20. PubMed ID: 12075739
[TBL] [Abstract][Full Text] [Related]
12. Raltitrexed. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
Gunasekara NS; Faulds D
Drugs; 1998 Mar; 55(3):423-35. PubMed ID: 9530547
[TBL] [Abstract][Full Text] [Related]
13. Ralitrexed (Tomudex) or Nordic-FLv regimen in metastatic colorectal cancer: a randomized phase II study focusing on quality of life, patients' preferences and health economics.
Norum J; Balteskard L; Edna TH; Laino R; Wählby L; Rønning G
J Chemother; 2002 Jun; 14(3):301-8. PubMed ID: 12120887
[TBL] [Abstract][Full Text] [Related]
14. [Raltitrexed and oxaliplatin in colorectal cancer: in vitro and in vivo study of a synergistic cytostatic combination].
Schüll B; Scheithauer W
Acta Med Austriaca; 2002; 29(4):124-31. PubMed ID: 12424937
[TBL] [Abstract][Full Text] [Related]
15. Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.
Avallone A; Di Gennaro E; Silvestro L; Iaffaioli VR; Budillon A
Expert Opin Drug Saf; 2014 Jan; 13(1):113-29. PubMed ID: 24093908
[TBL] [Abstract][Full Text] [Related]
16. Raltitrexed-based chemotherapy for advanced colorectal cancer.
Liu Y; Wu W; Hong W; Sun X; Wu J; Huang Q
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):219-25. PubMed ID: 24388340
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy with raltitrexed in patients with colorectal cancer intolerant of 5-fluorouracil: British Columbia Cancer Agency experience.
Wilson KS; Fitzgerald CA; Barnett JB; Gill S; Khoo KE
Cancer Invest; 2007 Dec; 25(8):711-4. PubMed ID: 18058467
[TBL] [Abstract][Full Text] [Related]
18. Raltitrexed in colorectal cancer.
Drug Ther Bull; 1996 Oct; 34(10):78-80. PubMed ID: 8936802
[TBL] [Abstract][Full Text] [Related]
19. Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
Popov I; Carrato A; Sobrero A; Vincent M; Kerr D; Labianca R; Raffaele Bianco A; El-Serafi M; Bedenne L; Paillot B; Mini E; Sanches E; Welch J; Collette L; Praet M; Wils J
Eur J Cancer; 2008 Oct; 44(15):2204-11. PubMed ID: 18707870
[TBL] [Abstract][Full Text] [Related]
20. Raltitrexed (tomudex) administration in patients failing multiple prior chemotherapy regimens in advanced colorectal cancer: a pilot study.
Tsavaris N; Kosmas C; Vadiaka M; Kontos A; Fotia M; Angelopoulou A; Vrizidis N; Soulla M; Sougioultzis S; Koufos Ch
Invest New Drugs; 2002 Feb; 20(1):133-6. PubMed ID: 12003191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]